Emergent BioSolutions Inc. - SIC # 7690 -

Ticker Exchange SIC # Website Latest Ticker
EBS New York 7690 www.emergentbiosolutions.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Emergent BioSolutions Inc.

Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcript - Nov 2nd, 2026 10:28 pm
Emergent Biosolutions: Q3 Earnings Snapshot - Nov 2nd, 2026 9:25 pm
Emergent Biosolutions Q3 Earnings Call Highlights - Nov 2nd, 2026 4:13 pm
Emergent Biosolutions Reports Third Quarter 2026 Financial Results - Nov 2nd, 2026 2:05 pm
Swedish Orphan Biovitrum (BIOVF) Tops Q3 Earnings and Revenue Estimates - Oct 27th, 2026 4:10 am
Emergent BioSolutions stock falls as CFO plans retirement - Oct 16th, 2026 9:41 am
Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl - Oct 16th, 2026 5:50 am
Bioscience Association Manitoba Welcomes New Board Members and Executive Members at Annual General Meeting - Oct 15th, 2026 2:10 pm
Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026 - Oct 15th, 2026 6:00 am
Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock? - Oct 6th, 2026 2:07 am
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards' - Oct 5th, 2026 9:34 pm
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility - Sep 15th, 2026 5:45 am
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva - Sep 7th, 2026 5:02 am
Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes - Sep 3rd, 2026 5:45 am
Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) - Sep 1st, 2026 5:55 am
Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray - Aug 31st, 2026 5:55 am
Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day - Aug 31st, 2026 5:54 am
Emergent BioSolutions (EBS) Q2 2026 Earnings Call Transcript - Aug 12th, 2026 4:13 pm